Kristin R. Davenport

Kristin R. Davenport

Kristin R. Davenport

Kristin Davenport is a counsel in the firm’s FDA Group and a member of the Life Sciences Practice. She concentrates on Food and Drug Administration laws. Ms. Davenport joined Goodwin in 2007.


Ms. Davenport counsels clients on a wide variety of FDA issues, with a focus on the medical device area. She has advised clients on matters relating to clinical investigations, pre-market submissions, pre-and post-market compliance, product exporting and importing and the Good Manufacturing Practices regulations. Ms. Davenport also advises companies with regard to food and dietary supplement matters.

Ms. Davenport regularly assists with conducting due diligences of medical device and drug companies, and has provided FDA-related litigation support.

Professional Activities

Ms. Davenport is a member of the American Bar Association, the Maryland State Bar Association and the District of Columbia Bar.

Professional Experience

Prior to joining Goodwin, Ms. Davenport was an associate in the FDA Department at WilmerHale.


While in law school, Ms. Davenport was a staff writer for the Boston College International and Comparative Law Review.



J.D., 2002
Boston College Law School
B.A., 1998
Georgetown University

(magna cum laude, Phi Beta Kappa)



District of Columbia
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Search Other Lawyers